Hamayak Sisakian | Cardiovascular Pharmacology | Research Excellence Award

Published on by Top Pharmaceutical

Prof. Hamayak Sisakian | Cardiovascular Pharmacology | Research Excellence Award

Yerevan State Medical University | Armenia

Prof. Hamayak Sisakian is a distinguished Armenian cardiologist whose career reflects exceptional commitment to clinical excellence, academic leadership, and internationally recognized contributions to cardiovascular medicine. His academic foundation began at the renowned Physics-Mathematics-focused Secondary School N1 in Yerevan, after which he completed his medical education at Yerevan State Medical University with high honors, graduating with a Red Diploma. He pursued advanced clinical training in internal diseases and cardiology at YSMU’s Department of Internal Diseases N1 and the Erebouni Medical Center, establishing the groundwork for a career dedicated to advancing the science and practice of cardiac care.Prof. Sisakian’s academic career spans progressive roles, starting as an Associate Professor and later advancing to a full professorship in the Department of Internal Diseases at YSMU’s University Hospital N1. He currently serves as the Head of the Department of General and Invasive Cardiology at the same institution, where he leads clinical programs, research initiatives, and the training of new generations of cardiologists. Additionally, he is Co-Founder and Co-Director of the Ultrasound Education University Center, an esteemed educational collaboration with Thomas Jefferson University Hospital’s Jefferson Ultrasound Research and Education Institute in Philadelphia, significantly advancing diagnostic ultrasound expertise in Armenia.His research achievements include the defense of notable theses, among them Cardioprotective Effect of the Products of Lymphocytes Activity and Clinical and Pathogenetic Characteristics of Myocardial Remodeling in Idiopathic Dilated Cardiomyopathy, which contributed to strengthening cardiology research at both national and international levels.

Citation Metrics (Google Scholar)

300

200

100

50

0

Citations
280

h-index
4

i10-index
2

Citations
h-index
i10-index


View Google Scholar Profile

Featured Publications

Yuqing Huo | Cardiovascular Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Yuqing Huo | Cardiovascular Pharmacology | Best Researcher Award

Baylor College of Medicine | United States

Prof. Yuqing Huo, Ph.D., is a distinguished cardiovascular and vascular biology researcher whose work bridges molecular mechanisms and clinical applications in inflammation, angiogenesis, and metabolic disease. A U.S. citizen with an extensive background in biomedical science, he currently serves as Professor and Danny B. Jones Chair at the Department of Ophthalmology, Department of Medicine/Section of Cardiovascular Research, and Department of Molecular and Cellular Biology at Baylor College of Medicine in Houston, Texas. His academic journey has been defined by a lifelong dedication to understanding vascular inflammation, endothelial function, and cellular metabolism in cardiovascular and ocular diseases.Prof. Huo earned his Medical Degree from Jining Medical College, followed by a Master’s in Cardiology from Qingdao University and a Doctoral Degree in Molecular Cardiology from Beijing Medical University. He further advanced his expertise as a Postdoctoral Research Associate in Inflammation and Vascular Biology at the University of Virginia, where he worked in Dr. Klaus Ley’s renowned laboratory at the Cardiovascular Research Center. His postdoctoral research laid the foundation for his later breakthroughs in vascular inflammation, monocyte recruitment, and endothelial interactions in atherosclerosis.Over his distinguished academic career, Prof. Huo has held faculty positions at several leading institutions, including the University of Virginia, the University of Minnesota, and Augusta University, where he served as Professor, Chief of the Vascular Inflammation Program, and Director of the Vision Discovery Institute. His leadership in the field has shaped numerous interdisciplinary programs that integrate cardiovascular and ocular research, expanding the understanding of inflammation and angiogenesis in chronic diseases.His scientific achievements have been widely recognized through numerous honors and awards, including distinctions from the American Heart Association, the American Physiological Society, and the American Diabetes Association. His accolades include the New Investigator Award, Young Investigator Award, and several institutional honors for outstanding research contributions and academic excellence.Prof. Huo’s active research focuses on “Myeloid glycolysis in pathological ocular angiogenesis,” “Myeloid PFKFB3 in subretinal fibrosis,” “Adenosine receptor 2A in subretinal fibrosis,” and “VSMC PFKFB3 in atherogenesis,” among others. His projects, supported by the National Institutes of Health (NIH) and the American Heart Association (AHA), aim to uncover novel molecular targets that regulate inflammation, fibrosis, and vascular remodeling. Through the use of genetically engineered models and molecular approaches, his research explores glycolytic reprogramming in immune cells and vascular tissues, paving the way for innovative therapeutic strategies in cardiovascular, metabolic, and ocular disorders.

Profile: Google Scholar

Featured Publications

Cheng, Y., Liu, X., Yang, J., Lin, Y., Xu, D. Z., Lu, Q., Deitch, E. A., Huo, Y., Delphin, E. S., & Zhang, C. (2009). MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circulation Research, 105(2), 158–166.

Huo, Y., Hafezi-Moghadam, A., & Ley, K. (2000). Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circulation Research, 87(2), 153–159.

Huo, Y., Schober, A., Forlow, S. B., Smith, D. F., Hyman, M. C., Jung, S., Littman, D. R., Weber, C., & Ley, K. F. (2003). Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nature Medicine, 9(1), 61–67.

Luo, X., Li, H., Ma, L., Zhou, J., Guo, X., Woo, S. L., Pei, Y., Knight, L. R., Deveau, M., Yang, S., & Huo, Y. (2018). Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice. Gastroenterology, 155(6), 1971–1984.e4.

Node, K., Huo, Y., Ruan, X., Yang, B., Spiecker, M., Ley, K., Zeldin, D. C., & Liao, J. K. (1999). Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science, 285(5431), 1276–1279.

Ramos, C. L., Huo, Y., Jung, U., Ghosh, S., Manka, D. R., Sarembock, I. J., & Ley, K. (1999). Direct demonstration of P-selectin– and VCAM-1–dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E–deficient mice. Circulation Research, 84(11), 1237–1244.

Aleksandra Klisic | Cardiovascular Pharmacology | Best Research Article Award

Published on by Top Pharmaceutical

Assoc. Prof. Dr. Aleksandra Klisic | Cardiovascular Pharmacology | Best Research Article Award

University of Montenegro-Faculty of Medicine | Montenegro

Assoc. Prof. Dr. Aleksandra Klisic is a distinguished medical scientist and academic leader from Montenegro, currently serving as an Associate Professor at the University of Montenegro, Faculty of Medicine, Podgorica. She also holds prominent positions as Chief and Quality Manager at the Center for Laboratory Diagnostics, Primary Health Care Center in Podgorica. With a strong foundation in clinical biochemistry and laboratory medicine, she has made significant contributions to the fields of endocrinology, diabetes, oxidative stress, and metabolic disorders.Dr. Klisic’s academic journey began at the University of Belgrade, where she earned her Doctor’s degree, Master’s degree, and Board Certification in Clinical Biochemistry. Her post-graduate specialization in Laboratory Endocrinology further strengthened her expertise in diagnostic and biochemical sciences. She has undergone advanced international training in biosafety, biosecurity, and laboratory leadership under global health programs organized in collaboration with the World Health Organization.Her research focuses on understanding the molecular and biochemical mechanisms underlying metabolic and cardiovascular diseases, emphasizing oxidative stress, inflammation, and hormonal regulation. Through her multidisciplinary studies, she explores the complex interactions between biochemical pathways and disease development, contributing to evidence-based laboratory and clinical practices.Dr. Klisic’s publications are widely recognized in high-impact scientific journals, reflecting her dedication to advancing clinical and translational research. Her work includes groundbreaking studies such as Association of Low Free T3 with Disease Presence and Activity in Ankylosing Spondylitis, Relationship Between Oxidative Stress and Cardiovascular Risk in Adolescents in Montenegro, SGLT2 Inhibitors and Cardiac Fibrosis: A Comprehensive Review, Role of Interleukins in Type 1 and Type 2 Diabetes, Oxidative Stress in Adolescents with Overweight/Obesity, and Association of Serum Selenium with Pro-atherogenic Adhesion Molecules, Inflammatory Cytokines and Carotid Intima-Media Thickness in Patients with Metabolic Syndrome. Her book chapter Antioxidant Supplementation and Cardiometabolic Syndrome (Elsevier) demonstrates her scholarly contribution to understanding reactive oxygen species and their role in chronic diseases.

Profile: Orcid

Featured Publications

Ciftel, E., Klisic, A., Kizilkaya, B., Cure, O., Mercantepe, F., Mataraci Karakas, S., & Ninić, A. (n.d.). Association of low free T3 with disease presence and activity in ankylosing spondylitis. International Journal of Molecular Sciences.

Klisic, A., Bozovic, M., Ostanek, B., Marc, J., Karakasis, P., Mercantepe, F., & Kotur-Stevuljevic, J. (n.d.). Relationship between oxidative stress and cardiovascular risk in adolescents in Montenegro. International Journal of Molecular Sciences.

Veljkovic, A., Stanojevic, G., Brankovic, B., Roumeliotis, S., Leivaditis, K., Djordjevic, B., Li, X., Klisic, A., Hadzi-Djokic, J., & Kocic, G. (n.d.). MMP-9 activation via ROS/NF-κB signaling in colorectal cancer progression: Molecular insights and prognostic–therapeutic perspectives. Current Issues in Molecular Biology.

Asif, R., Khalid, A., Mercantepe, T., Klisic, A., Rafaqat, S., Rafaqat, S., & Mercantepe, F. (n.d.). Role of interleukins in type 1 and type 2 diabetes. Diagnostics.

Pishdadian, A., Sharifi, R., Shafaghi, A., Hamedi-Shahraki, S., Amirkhizi, F., & Klisic, A. (n.d.). Association of serum selenium with clinical features and inflammatory and oxidative stress markers in Iranian patients with metabolic dysfunction-associated steatotic liver disease—A cross-sectional study. Diagnostics.

Erceg, S., Munjas, J., Sopić, M., Tomašević, R., Mitrović, M., Kotur-Stevuljević, J., Mamić, M., Vujčić, S., Klisic, A., & Ninić, A. (n.d.). Expression analysis of circulating miR-21, miR-34a and miR-122 and redox status markers in metabolic dysfunction-associated steatotic liver disease patients with and without type 2 diabetes. International Journal of Molecular Sciences.

Samavarchitehrani, A., Mercantepe, F., Behnoush, A. H., & Klisic, A. (n.d.). Exploring the TyG index and the homeostasis model assessment of insulin resistance as insulin resistance markers: Implications for fibromyalgia management and understanding—A narrative review. Diagnostics.

Ćeriman Krstić, V., Jovanović, D., Samardžić, N., Gajić, M., Kotur Stevuljević, J., Klisic, A., Soldatović, I., Radončić, D., Roksandić Milenković, M., & Šeha, B. (n.d.). The potential role of sPD-L1 as a predictive biomarker in EGFR-positive non-small-cell lung cancer. Current Issues in Molecular Biology.

Di Yang | Cardiovascular Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Assoc. Prof. Dr. Di Yang | Cardiovascular Pharmacology | Best Researcher Award

Fudan University | China

Assoc. Prof. Dr. Di Yang is a distinguished researcher in the field of cardiovascular pharmacology with an academic journey beginning at Harbin Medical University, where he completed both his B.S. and M.S. degrees in Pharmacy and Pharmacology, respectively, followed by a Ph.D. in Cardiovascular Pharmacology from the School of Pharmacy, Fudan University. Currently serving as an Associate Professor at the Human Phenome Institute, Fudan University, Dr. Yang has developed a remarkable research career with postdoctoral training at Fudan University’s Basic Medical Sciences and an extensive record of competitive research grants, including multiple projects funded by the National Natural Science Foundation of China and the Shanghai Municipal Science and Technology Commission. His innovative work spans vascular biology, cardiovascular aging, epigenetics, and metabolic disorders, focusing on critical mechanisms involving pyruvate dehydrogenase kinase 4, histone methyltransferases SMYD2 and SMYD3, and m6A demethylase ALKBH5 in vascular remodeling, endothelial aging, and cardiac hypertrophy. As a prolific author, Dr. Yang has contributed significantly to high-impact journals with key publications such as The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy, Poly (ADP-ribose) polymerases 16 triggers pathological cardiac hypertrophy via activating IRE1α-sXBP1-GATA4 pathway, Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity, Histone methyltransferase Smyd2 drives adipogenesis via regulating STAT3 phosphorylation, H3K4 methyltransferase Smyd3 mediates vascular smooth muscle cell proliferation, migration and neointima formation, The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis, Histone methyltransferase Smyd3 is a new regulator for vascular senescence.

Profile: Orcid

Featured Publications

Chen, M., & Yang, D. (2025). Current insights into obesity and m6A modification. Biomedicines, 13(9), 2164.

Chen, M., Su, H., Shu, M., Shen, F., Lu, Y., Wu, S., Su, Z., Yu, M., & Yang, D. (2024). The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy. Cell Death & Disease, 15, 285.

Su, H., Xu, J., Su, Z., Xiao, C., Wang, J., Zhong, W., Meng, C., Yang, D., & Zhu, Y. (2023). Poly (ADP-ribose) polymerases 16 triggers pathological cardiac hypertrophy via activating IRE1α–sXBP1–GATA4 pathway. Cellular and Molecular Life Sciences, 80, 159.

Su, H., Meng, C., Xu, J., Su, Z., Xiao, C., & Yang, D. (2022). Histone methyltransferase Smyd2 drives adipogenesis via regulating STAT3 phosphorylation. Cell Death & Disease, 13, 899.

Sapna B A | Cardiovascular Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Sapna B A | Cardiovascular Pharmacology | Best Researcher Award

Assitant Professor at KIT-Kalaignarkarunanidhi Institute of Technology | India

Dr. Sapna B A is an accomplished academic and researcher in the field of information and communication engineering, specializing in antenna design for biomedical, wearable, and wireless applications. With a strong foundation in electronics and communication, she has contributed significantly to developing advanced implantable and wearable antennas, focusing on safety and performance enhancements. Her career spans both academia and industry, with expertise ranging from teaching and mentoring to leading design projects in Dubai’s technology sector. Currently serving as Assistant Professor at Kalaignarkarunanidhi Institute of Technology, Coimbatore, she is recognized for impactful research, funded projects, and award-winning publications in reputed journals.

Publication Profile 

Orcid

Education 

Dr. Sapna B A earned her Ph.D. in Information and Communication Engineering from Anna University under the guidance of Dr. G. Srivatsun at PSG College of Technology, Coimbatore, with her thesis titled “High Performance Antennas for UWB Applications.” She completed her M.E. in Communication Systems from B S A Crescent Engineering College, Chennai, affiliated to Anna University, with a commendable. Her undergraduate studies were in Electronics and Communication Engineering at Jerusalem College of Engineering, University of Madras, where she obtained her B.E. degree. Her education has laid a strong academic foundation for her research in RF, antennas, and communication systems.

Experience 

Dr. Sapna B A has over two decades of diverse professional experience in academia and industry. She is currently an Assistant Professor at Kalaignarkarunanidhi Institute of Technology, Coimbatore, leading the Ansys 5G Antenna Innovation Hub and successfully completing AICTE-funded projects. Previously, she was a Research Scholar at PSG College of Technology, where she worked extensively on planar and UWB antenna development. Her academic journey also includes faculty positions at INFO Institute of Engineering, RVS College of Engineering, B S A Crescent Engineering College, and CSI College of Engineering. She also served in Dubai as a Design & Estimation Engineer.

Awards and Honors 

Dr. Sapna B A has received several prestigious recognitions for her research and teaching excellence. She was honored with the Best Paper Award for her work on an implantable endoscopic antenna at an IEEE-sponsored international conference. She received the Faculty Excellence Award SNS Institutions for outstanding contributions in research and publication. Her dedication to impactful research has earned her multiple cash awards, Kalaignarkarunanidhi Institute of Technology. Her achievements highlight her commitment to innovation in antenna design and her consistent contributions to advancing communication engineering research.

Research Focus 

Dr. Sapna B A’s research is centered on high-performance antennas for wireless communication, wearable systems, and biomedical applications. She has specialized in designing compact, flexible, and biocompatible implantable antennas with low specific absorption rates to ensure patient safety in medical telemetry. Her work extends to planar and UWB antennas, bandwidth enhancement, gain improvement techniques, and frequency selective surfaces. She has contributed significantly to wearable antenna systems for healthcare monitoring, WBAN applications, and cancer detection. Through experimental validation and simulation studies, her research bridges practical biomedical needs with advanced RF design, positioning her as a leading contributor in antenna engineering.

Publication Top Notes